抽象的な

Recombinant Protein Bioprocessing

Bonnie David

Recombinant protein synthesis is essential for both the discovery of novel protein therapeutics and the structural identification of pharmacological targets. Recombinant protein manufacturing therefore plays a significant part in the creation of pharmaceuticals. Around 30% of the biopharmaceuticals now available on the market are produced using recombinant proteins that are frequently produced on bacterial hosts. I outline key ideas in this review related to the creation of drugs and production scales for recombinant proteins in bacteria. How can this failure be minimised to quickly give maximal quantities of high-quality protein and so speed up drug discovery? Recombinant protein manufacturing systems frequently experience failure.